The ALBATROS Grand Prize for original research at been delivered to:
Victor Echeverry-Alzate,INSERM U1247, Amiens: “Revisiting baclofen in the treatment of alcoholism: just a question of enantiomer? “
The risk benefit of baclofen in the treatment of alcohol dependence remains controversial. It is important to better characterize the factors that influence efficacy and adverse effects, as well as the variability of individual responses. Recent data show that the effect of baclofen may depend on the enantiomer. This is the whole purpose of Victor Echeverry-Alzate’s study. His work in rats shows that R (+) – baclofen may be more effective than (±) -baclofen in the treatment of alcohol dependence. Data analysis is underway to determine whether the efficacy of baclofen is dependent on individual characteristics.
Members of the jury:
Georges Brousse, Clermont Ferrand University Hospital
Olivier Cottencin, Lille University Hospital
Amine Benyamina, Paul Brousse Hospital, Villejuif
The CAMURUS Grand Prize for the best clinical innovation was awarded to:
Aurélia Gay , CHU de Saint-Etienne: “Interest of repetitive transcranial magnetic stimulation in gambling addiction”
The ban on gambling and gambling is a common and debilitating condition for which no biological treatment has been validated. Aurélia Gay worked on a study in pathological gamblers, which showed the effectiveness of repetitive transcranial magnetic stimulation (rTMS) on craving. It was carried out on 22 pathological gamblers, who received an active high-frequency rTMS session and a placebo session 7 days apart, applied to the left dorsolateral prefrontal cortex (CPFDL). Before and after each session, subjects performed cognitive tests and rated their craving on a visual analog scale before and after a video game. The results show that rTMS is a promising therapeutic avenue in addictive disorders.
Members of the jury:
Elisabeth Avril, general manager of the Gaia association, Paris
Lisa Blecha, Paul Brousse hospital, Villejuif
Mélina Fatseas, Bordeaux University Hospital
The Special ALBATROS Grand Prix Junior Addictologist in partnership with AJPJA and AFFEPhas been delivered to:
Benoît Schreck, intern in psychiatry, Nantes: “Sex, drug and slam”
For nearly ten years, slam has emerged in France. It is a practice combining sex and the consumption of psychostimulant substances, mainly from the family of synthetic cathinones. Benoît Schreck presents a study that has just been set up, QualiSlam, the objective of which is to identify the motivations of users to practice slam and to offer new perspectives of care to these people.
Members of the jury:
This is not a classic jury. The prize was awarded following the session “The Voice of Addiction”.
• The ALBATROS Prize for Original Research : this € 2,000 prize rewards the most innovative clinical or fundamental research, the results of which are likely to be published in a peer-reviewed journal.
• The CAMURUS Prize for the best clinical innovation : this € 2,000 prize rewards the work of a team that innovates and improves patient care. The results obtained or expected and the presentation of the work are taken into account.
• The Special ALBATROS Junior Addictologist Prize in partnership with AJPJA (Association of Young Psychiatrists and Young Addictologists) and AFFEP (French Federation of Psychiatry Students) : this price of € 1,000 is intended to reward the innovative work of a young researcher, intern, head of clinic or during a thesis.
Professor Amin BENYAMINA is pleased to invite you to the 12th edition of the International Congress of the Albatros which will take place on Wednesday 6, Thursday 7 and Friday, June 8, 2018 in New Cap Event Center (Paris 15th).
The ALBATROS congress is an unmissable event in the field of addictology. It brings together actors from all walks of life: academics, clinicians, researchers. This is an opportunity to meet world experts to discuss hot topics. This 12th edition will host, among others, the Professor Nora Volkow, President of NIDA (National Institute on Drug Abuse), the Professor Gilberto Gerra, UN Drugs and Crime Division , and the Pr Pedro Ruiz, directeur de la World Association of Dual DisordersProf. Pedro Ruiz, director of the World Association of Dual Disorders .
This year, the theme will be: “Addictions: from the challenge of prevention to therapeutic innovation”. If France is at the forefront in the curative field, it must take up the challenge of prevention.
«Prevention can only be effective if it innovates , underlines Prof. Benyamina. And it will be necessary to innovate to avoid the pitfalls that certain States know in terms of overdose “.
Nora Volkow (USA) will explain how the United States found itself in this public health crisis, with a very strong increase in overdoses, and the solutions to get out of it.
> Patricia Conrod (Quebec) will present a innovative intervention in schools to prevent addictions among young people.
> Very interesting research on sugar will be presented by Serge Ahmed (Bordeaux). They show that sugar is an even more addictive substance than cocaine.
> Pedro Ruiz (USA) will talk about the revolution in the approach to dual pathologies .
Further communications with leading international specialists will address topics such as co-morbidities and hepatitis C. ” This pathology must be eradicated by 2025 according to the objectives of the National Public Health Plan, and its eradication must go through the consideration of addicted patients », Insists Professor Benyamina.
This year, 3 Grand Prizes will be awarded:
> ALBATROS Prize for Original Research
> CAMURUS Award for Best Clinical Innovation
> ALBATROS Special Junior Addictologist Prize
Simultaneous French-English translation is provided.
We remain at your disposal to organize, if you wish, interviews during the congress with the experts present.
We look forward to welcoming you on June 6.
Best regards.
PRESS RELATIONS ALBATROS Congress
Sandrine CHAUVARD
Journalist-Scientific Manager
+ 33 (0) 1.84.20.11.95
+ 33 (0) 6.85.24.42.73
Annie EGGERMANN
+ 33 (0) 1.84.20.11.92
+ 33 (0) 6.07.78.50.83
E-mail : a.eggermann@katanasante.com
KATANA santé
29 rue Camille Pelletan
92300 Levallois Perret – France
www.katanasante.com